ATRC AtriCure, Inc. - Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · atricure.com

54.22USD-1.66%Mkt Cap: 2.80B $P/E: 262.57Today

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap2.80B USD

Enterprise Value2.71B USD

Revenue (TTM)569.62M USD

Gross Profit400.78M USD

Net Income (TTM)-11.45M USD

Revenue/Share11.81 USD

Last Price54.22 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.4K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)262.57

P/E (Forward)127.06

PEG10.00

EV/EBITDA80.34

EV/Revenue4.76

P/S4.92

P/B5.43

EPS (TTM)0.21

EPS (Forward)0.43

52W Range

25.3779% of range61.70

52W High61.70 USD

52W Low25.37 USD

Profitability

Gross Margin74.98%

Oper. Margin6.29%

EBITDA Margin5.92%

Profit Margin-2.14%

ROE-2.33%

ROA-1.75%

Growth

Revenue Growth12.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF57.33M USD

CapEx (TTM)15.05M USD

FCF Margin8.57%

FCF Yield1.74%

Net Debt-93.56M USD

Net Debt/EBITDA-2.77

Balance Sheet

Debt/Equity0.15

Current Ratio4.22

Quick Ratio3.02

Book Value/Sh10.15 USD

Cash/Share3.30 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)54.89 USD

Upside (mean)+1.2%

Target Range36.00 USD – 65.00 USD

36.00+1.2% to mean65.00

# Analysts9

Ownership

Shares Out.50.87M

Float48.83M

Insiders3.76%

Institutions105.82%

Short Interest

Short Ratio4.5d

Short % Float8.76%

Short % Out.8.41%

Shares Short4.28M

Short (prev mo.)3.92M

Technical

SMA 5049.11 (+10.4%)

SMA 20036.34 (+49.2%)

Beta1.26

S&P 52W Chg14.58%

Avg Vol (30d)1.28M

Avg Vol (10d)1.27M

Technical Indicators

RSI (14)56.3

MACD2.7841

MACD Signal3.7231

MACD Hist.-0.9390

BB Upper61.51 USD

BB Middle55.93 USD

BB Lower50.35 USD

BB Width19.96%

ATR (14)2.457 USD

Vol Ratio (20d)1.02x